ECSP961893A - (METHYL SULFONIL) PHENYL -2- (5H) - FURANOMAS AS COX INHIBITORS - 2 '' - Google Patents
(METHYL SULFONIL) PHENYL -2- (5H) - FURANOMAS AS COX INHIBITORS - 2 ''Info
- Publication number
- ECSP961893A ECSP961893A ECSP961893A ECSP961893A EC SP961893 A ECSP961893 A EC SP961893A EC SP961893 A ECSP961893 A EC SP961893A EC SP961893 A ECSP961893 A EC SP961893A
- Authority
- EC
- Ecuador
- Prior art keywords
- furanomas
- sulfonil
- phenyl
- methyl
- cox inhibitors
- Prior art date
Links
- 229940124638 COX inhibitor Drugs 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 2
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000001404 mediated effect Effects 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invención abarca el compuesto novedoso de fórmula I, útil en el tratamiento de enfermedades mediadas por ciclooxigenasa-2 (gráfico), La invención también abarca ciertas formulaciones farmacéuticas para el tratamiento de enfermedades mediadas por ciclooxigenasa-2 que comprende compuesto de la fórmula IThe invention encompasses the novel compound of formula I, useful in the treatment of cyclooxygenase-2 mediated diseases (graph), The invention also encompasses certain pharmaceutical formulations for the treatment of cyclooxygenase-2 mediated diseases comprising compound of formula I
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961893 ECSP961893A (en) | 1996-10-10 | 1996-10-10 | (METHYL SULFONIL) PHENYL -2- (5H) - FURANOMAS AS COX INHIBITORS - 2 '' |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961893 ECSP961893A (en) | 1996-10-10 | 1996-10-10 | (METHYL SULFONIL) PHENYL -2- (5H) - FURANOMAS AS COX INHIBITORS - 2 '' |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961893A true ECSP961893A (en) | 1997-10-17 |
Family
ID=42042619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961893 ECSP961893A (en) | 1996-10-10 | 1996-10-10 | (METHYL SULFONIL) PHENYL -2- (5H) - FURANOMAS AS COX INHIBITORS - 2 '' |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961893A (en) |
-
1996
- 1996-10-10 EC ECSP961893 patent/ECSP961893A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE03969B1 (en) | (Methylsulfonyl) phenyl-2- (5H) -furanones, their Use and Pharmaceutical Compositions | |
| ES2186015T3 (en) | DERIVATIVES OF 2- (PURIN-9-IL) -TETRAHIDROFURAN-3,4-DIOL. | |
| ES2115237T3 (en) | PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS. | |
| ES2139959T3 (en) | STYLENE DERIVATIVES USEFUL AS CYCLOOXYGENASE-2 INHIBITORS. | |
| BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
| AR014261A1 (en) | BENZOTIAZEPINE HYPOLIPIDEMIC COMPOUNDS, COMPOSITIONS AND PROCESS FOR PREPARATION | |
| CO4930259A1 (en) | DERIVATIVES 6,6-HETEROBICICLICOS SUBSTITUTED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| BR0116052A (en) | imidazoquinolines substituted by aryl ether | |
| BR9900320A (en) | Antimicrobial composition | |
| UY26130A1 (en) | COMPOUNDS TO TREAT OBESITY | |
| PA8583401A1 (en) | NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF) | |
| PA8452701A1 (en) | PROSTAGLANDIN AGONISTS | |
| PT1246809E (en) | 5-ARYL-1H-1,2,4-TRIAZOLE COMPOUNDS AS CICLOOXYGENASE-2 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| BR9708114A (en) | Xanthone analogues for the treatment of infectious diseases. | |
| MX9704037A (en) | 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof. | |
| AR021843A1 (en) | DERIVATIVES OF PROPANOLAMINE SUBSTITUTED WITH HETEROCICLES, PROCEDURE FOR THEIR PREPARATION, AND ITS USE. | |
| BR9916575A (en) | Pharmaceutical composition of controlled release with tilidine mesylate as active substance | |
| SE9804212D0 (en) | Compounds | |
| SE9801494D0 (en) | Novel use | |
| AR020563A1 (en) | TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE | |
| ES2182035T3 (en) | DERIVATIVES OF BISARILCICLOBUTENO AS CICLOOXIGENASA INHIBITORS | |
| DE69816047D1 (en) | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer | |
| ES2147973T3 (en) | RENTED STYLES AS COX-2 INHIBITOR PROPHARMACS. | |
| MX9704034A (en) | DERIVATIVES AND COMPOSITIONS OF SUBSTITUTED 2-ARYLCARBONYLOXYMETHYL-1,2,5-TIADIAZOLIDIN-3-ONA 1,1-DIOXIDE AND METHOD OF USE. | |
| NO983511D0 (en) | Diphenylstilbenes as prodrugs for COX-2 inhibitors |